Law360, New York (September 09, 2009) -- Attorneys for indirect purchaser plaintiffs in a class action accusing Abbott Laboratories and Fournier Industrie et Sante of blocking generic competition for cholesterol drug TriCor have asked a federal judge to award them almost $22 million in fees — one-third of a $65.7 million class settlement fund.
The indirect purchaser class plaintiffs' motion, filed Tuesday, also asked Judge Sue L. Robinson of the U.S. District Court for the District of Delaware to reimburse them for more than...
